Acute Myocardial Infarction (AMI) Diagnosis; Impact of Technology in Developing Highly Sensitive Biomarkers and Assays

References (52)

1. 1 Inflammation, Atherosclerosis, and Coronary Artery Disease [DOI]
2. 2 Universal Definition of Myocardial Infarction [DOI]
3. 3 Myocardial infarction redefined—A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction [DOI]
4. 4 Sensitive optical biosensors for unlabeled targets: A review [DOI]
5. 5 Cardiac-Specific Troponin I Levels to Predict the Risk of Mortality in Patients with Acute Coronary Syndromes [DOI]
6. 6 Update on acute coronary syndromes: the pathologists' view [DOI]
7. 7 Immune Effector Mechanisms Implicated in Atherosclerosis: From Mice to Humans [DOI]
8. 8 Troponin elevation in coronary vs. non-coronary disease [DOI]
9. 9 Characterization of dissolved organic matter in cave and spring waters using UV–Vis absorbance and fluorescence spectroscopy [DOI]
10. 10 Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations [DOI]
11. 11 Utility of Absolute and Relative Changes in Cardiac Troponin Concentrations in the Early Diagnosis of Acute Myocardial Infarction [DOI]
12. 12 Clinical Laboratory Practice Recommendations for the Use of Cardiac Troponin in Acute Coronary Syndrome: Expert Opinion from the Academy of the American Association for Clinical Chemistry and the Task Force on Clinical Applications of Cardiac Bio-Markers of the International Federation of Clinical Chemistry and Laboratory Medicine [DOI]
13. 13 A New Season for Cardiac Troponin Assays: It’s Time to Keep a Scorecard [DOI]
14. 14 Incremental Value of Copeptin for Rapid Rule Out of Acute Myocardial Infarction [DOI]
15. 15 Cardiac Troponin Assays: Guide to Understanding Analytical Characteristics and Their Impact on Clinical Care [DOI]
16. 16 Differential diagnosis of elevated troponins [DOI]
17. 17 Acute Coronary Syndromes: Diagnosis and Management, Part I [DOI]
18. 18 Biomarkers in acute myocardial infarction [DOI]
19. 19 Early diagnosis of acute myocardial infarction in the elderly using more sensitive cardiac troponin assays [DOI]
20. 20 Diagnostics on acute myocardial infarction: Cardiac troponin biomarkers [DOI]
21. 21 Troponin I and cardiovascular risk prediction in the general population: the BiomarCaRE consortium [DOI]
22. 22 National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Use of Cardiac Troponin and B-Type Natriuretic Peptide or N-Terminal proB-Type Natriuretic Peptide for Etiologies Other than Acute Coronary Syndromes and Heart Failure [DOI]
23. 23 The utility of troponin measurement to detect myocardial infarction: review of the current findings [DOI]
24. 24 Assessing the Requirement for the 6-Hour Interval between Specimens in the American Heart Association Classification of Myocardial Infarction in Epidemiology and Clinical Research Studies [DOI]
25. 25 Recent Development of Cardiac Troponin I Detection [DOI]
26. 26 Troponin T isoforms and posttranscriptional modifications: Evolution, regulation and function [DOI]
27. 27 Renal Elimination of Troponin T and Troponin I [DOI]
28. 28 What to do when you question cardiac troponin values [DOI]
29. 29 Cardiac Troponins: Contemporary Biological Data and New Methods of Determination [DOI]
30. 30 Cardiac troponin: a critical review of the case for point-of-care testing in the ED [DOI]
31. 31 Thrombin-Mediated Degradation of Human Cardiac Troponin T [DOI]
32. 32 Urine high sensitive Troponin I measuring in patients with hypertension [DOI]
33. 33 Troponin I as a Biomarker for Early Detection of Acute Myocardial Infarction [DOI]
34. 34 Cardiac Markers in the Early Diagnosis and Management of Patients with Acute Coronary Syndrome [DOI]
35. 35 Prognostic value of cardiac troponin in chronic stable heart failure: a systematic review [DOI]
36. 36 Cardiac Troponin Assays [DOI]
37. 37 Immune Effector Mechanisms Implicated in Atherosclerosis: From Mice to Humans [DOI]
38. 38 A Rapid and Simple LC–MS/MS Method for The Simultaneous Evaluation of Cyp1A2, Cyp2C9, Cyp2C19, Cyp2D6 and Cyp3A4 Hydroxylation Capacity [DOI]
39. 39 The efficacy of combining several risk factors as a screening test [DOI]
40. 40 Rapid and sensitive cardiac troponin I immunoassay based on fluorescent europium(III)-chelate-dyed nanoparticles [DOI]
41. 41 Methodological and Analytic Considerations for Blood Biomarkers [DOI]
42. 42 “Ultra-sensitive” cardiac troponins: Requirements for effective implementation in clinical practice [DOI]
43. 43 Мутации сердечных тропонинов, ассоциированные с кардиомиопатиями [DOI]
44. 44 Cardiac enzymes [DOI]
45. 45 Troponins: Not Always a Myocardial Infarction [DOI]
46. 46 EARLY LABORATORY INDICATORS OF ACUTE MYOCARDIAL INFARCTION [DOI]
47. 47 Multiplex Flow Assays [DOI]
48. 48 Cardiac Troponin Scorecard [DOI]
49. 49 The problem(s) with troponin [DOI]
50. 50 Evaluation of Seven Immunoassays Not Commonly Used in Toxicology [DOI]
51. 51 The universal definition of myocardial infarction [DOI]
52. 52 The universal definition of myocardial infarction: some issues and concerns: reply [DOI]

Cited by 3

Showing 2 of 3 known citations — external sources report more than can currently be individually listed.

Related research

• Maternal Age and Congenital Anomalies among Newborns in a Tertiary Health Facility in Benue State, North Central Nigeria — shares topic coverage
• Early Diagnosis of Neonatal Sepsis: A Review of the Current Methods in Clinical Practice — shares topic coverage
• Skeletal Dysplasia: Approach to Simplify Diagnosis, Looking for Radiographic Clue Signs — shares topic coverage
• Impact of Radiology on the Early Identification of Waterhouse-friderichsen Syndrome: A Case Study — shares topic coverage
• The Impact of Genexpert MTB/RIF Technology on the Minimization of Tuberculosis: A Review of Literature — shares topic coverage